Troy A. Reaves

405 total citations
10 papers, 293 citations indexed

About

Troy A. Reaves is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Troy A. Reaves has authored 10 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Pharmacology. Recurrent topics in Troy A. Reaves's work include Glaucoma and retinal disorders (7 papers), Ocular Surface and Contact Lens (5 papers) and Retinal Diseases and Treatments (3 papers). Troy A. Reaves is often cited by papers focused on Glaucoma and retinal disorders (7 papers), Ocular Surface and Contact Lens (5 papers) and Retinal Diseases and Treatments (3 papers). Troy A. Reaves collaborates with scholars based in United States, China and Switzerland. Troy A. Reaves's co-authors include Thomas M. Aaberg, Robert H. Stewart, Michel Sickenberg, Paul W. Sternberg, David A. Saperstein, Philip J. Rosenfeld, Neil M. Bressler, Bernard E. McCarey, Robert H. Rosa and Peter J. McDonnell and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Cornea.

In The Last Decade

Troy A. Reaves

10 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Troy A. Reaves United States 10 228 89 85 48 17 10 293
Charles S. Ostrov United States 8 321 1.4× 306 3.4× 148 1.7× 40 0.8× 14 0.8× 9 446
Paul J. Wasson United States 7 203 0.9× 138 1.6× 63 0.7× 8 0.2× 49 2.9× 7 330
Daniel Byles United Kingdom 7 229 1.0× 96 1.1× 30 0.4× 15 0.3× 16 0.9× 13 245
Jean-Marc Guenoun France 6 329 1.4× 176 2.0× 252 3.0× 29 0.6× 19 1.1× 7 380
Mario G. Fsadni United Kingdom 9 279 1.2× 139 1.6× 80 0.9× 32 0.7× 50 2.9× 25 349
Ricardo Lamy United States 8 201 0.9× 184 2.1× 53 0.6× 6 0.1× 42 2.5× 19 295
Paola Camicione Italy 7 111 0.5× 84 0.9× 131 1.5× 4 0.1× 16 0.9× 11 280
James P. Guzek United States 9 356 1.6× 121 1.4× 80 0.9× 16 0.3× 30 1.8× 12 383
Paul J Gomes United States 15 101 0.4× 57 0.6× 416 4.9× 29 0.6× 16 0.9× 58 539
Mark C Jasek United States 7 370 1.6× 229 2.6× 266 3.1× 14 0.3× 10 0.6× 9 428

Countries citing papers authored by Troy A. Reaves

Since Specialization
Citations

This map shows the geographic impact of Troy A. Reaves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troy A. Reaves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troy A. Reaves more than expected).

Fields of papers citing papers by Troy A. Reaves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Troy A. Reaves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troy A. Reaves. The network helps show where Troy A. Reaves may publish in the future.

Co-authorship network of co-authors of Troy A. Reaves

This figure shows the co-authorship network connecting the top 25 collaborators of Troy A. Reaves. A scholar is included among the top collaborators of Troy A. Reaves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Troy A. Reaves. Troy A. Reaves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Rosenfeld, Philip J., David A. Saperstein, Neil M. Bressler, et al.. (2004). Photodynamic therapy with verteporfin in ocular histoplasmosis: Uncontrolled, open-label 2-year study. Ophthalmology. 111(9). 1725–1733. 32 indexed citations
2.
Saperstein, David A., Philip J. Rosenfeld, Neil M. Bressler, et al.. (2002). Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome. Ophthalmology. 109(8). 1499–1505. 55 indexed citations
3.
McCarey, Bernard E. & Troy A. Reaves. (1997). Effect of tear lubricating solutions on in vivo corneal epithelial permeability. Current Eye Research. 16(1). 44–50. 9 indexed citations
4.
Laibovitz, Robert, et al.. (1995). Safety and Efficacy of Diclofenac Sodium 0.1% Ophthalmic Solution in Acute Seasonal Allergic Conjunctivitis. Journal of Ocular Pharmacology and Therapeutics. 11(3). 361–368. 22 indexed citations
5.
McCarey, Bernard E., et al.. (1995). Corneal Wound Healing Strength with Topical Antiinflammatory Drugs. Cornea. 14(3). 290–294. 25 indexed citations
6.
Szerenyi, Karin, et al.. (1995). Effect of Diclofenac on Corneal Haze after Photorefractive Keratectomy in Rabbits. Ophthalmology. 102(3). 469–474. 33 indexed citations
7.
Reaves, Troy A., et al.. (1995). Noninvasive measurement of corneal epithelial permeability. Current Eye Research. 14(6). 505–510. 13 indexed citations
8.
Abrams, Donald A., et al.. (1989). A Limited Comparison of Apraclonidine's Dose Response in Subjects with Normal or Increased Intraocular Pressure. American Journal of Ophthalmology. 108(3). 230–237. 38 indexed citations
9.
Stewart, Robert H., et al.. (1988). Suprofen Treatment of Contact Lens-associated Giant Papillary Conjunctivitis. Ophthalmology. 95(6). 822–826. 20 indexed citations
10.
Stark, W J, et al.. (1986). Reduction of Pupillary Constriction During Cataract Surgery Using Suprofen. Archives of Ophthalmology. 104(3). 364–366. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026